DeepMed Research

Barcelona Institute for Global Health

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: Private

Established: 2010-01-01

Employees: -

Market Cap: -

Website: https://www.isglobal.org/ca/

Clinical Trials

Preparing for Maternal GBS Vaccine Trials in Africa

Recruiting

Conditions: Group B Streptococcus
Invasive Bacterial Diseases (IBD)
Maternal Immunization

First Posted Date: 2025-02-19

Last Posted Date: 2025-05-02

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 18100

Registration Number: NCT06833957

Locations: 🇲🇼
Ndirande Health Centre, Blantyre, Malawi
🇰🇪
Mariakani Sub-County Hospital, Mariakani, Coast, Kenya
🇰🇪
Rabai Sub County Hospital, Rabai, Kilifi, Kenya

and more 6 locations

Nature Based Therapy With Mindful Walks in Urban Coastal Settings for Metabolic Syndrome - Barcelona (Spain)

Not Applicable

Recruiting

Conditions: Metabolic Syndrome X
Stress

Interventions: Other: Nature based Therapy (NbT)

First Posted Date: 2024-10-02

Last Posted Date: 2024-10-02

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 140

Registration Number: NCT06622629

Locations: 🇪🇸
ISGlobal, Barcelona, Spain

L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

Not Applicable

Not yet recruiting

Conditions: Child, Only
Infectious Disease
Infections

Interventions: Dietary Supplement: L-citrulline
Dietary Supplement: Placebo

First Posted Date: 2024-05-23

Last Posted Date: 2024-05-23

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 2200

Registration Number: NCT06426147

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Not Applicable

Not yet recruiting

Conditions: Child, Only
Febrile Illness
Infectious Disease

Interventions: Other: IMCI-enhanced by sTREM-1 levels (SoC + sTREM-1 POC)

First Posted Date: 2024-05-21

Last Posted Date: 2024-05-24

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 5212

Registration Number: NCT06422338

COPD Exacerbation Modelling Using Unobtrusive Sensors - the TOLIFE Clinical Study A

Recruiting

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

First Posted Date: 2023-12-15

Last Posted Date: 2024-05-20

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 150

Registration Number: NCT06172712

Locations: 🇩🇪
Pulmonary Research Institute, Großhansdorf, Schleswig-Holstein, Germany
🇮🇹
Azienda Ospedaliero Universitaria Pisana, Pisa, Italy
🇪🇸
Hospital del Mar Research Institute, Barcelona, Spain

Delivering a Multi-disease Screening Tool to Migrant Populations

Not Applicable

Completed

Conditions: Strongyloidiasis
Chagas Disease
Female Genital Mutilation Type II Status
Tuberculosis
Female Genital Mutilation Type III Status
Hepatitis B
Hepatitis C
Schistosomiasis
Female Genital Mutilation Type I Status
Hiv

Interventions: Other: Clinical decision support system for screening of migrants using the ISMiHealth software tool.

First Posted Date: 2023-05-22

Last Posted Date: 2025-05-13

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 980

Registration Number: NCT05868005

Locations: 🇪🇸
Servicio Andaluz de Salud (SAS) (administration of the participant PCCs in Andalusia), Almería, Andalusia, Spain
🇪🇸
Institut Català de la Salut (ICS) (administration of the participant PCCs in Catalonia), Tortosa, Catalonia, Spain

Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations

Active, not recruiting

Conditions: COVID-19
SARS-CoV2 Infection

First Posted Date: 2022-03-31

Last Posted Date: 2024-03-12

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 1000

Registration Number: NCT05303168

Locations: 🇬🇦
Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon
🇲🇿
Centro de Investigação em Saúde de Manhiça (CISM), Manhiça, Mozambique

Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms

Phase 2

Terminated

Conditions: Helminthes; Infestation, Intestinal

Interventions: Combination Product: Albendazole and Ivermectin fixed dose coformulation
Drug: Albendazole

First Posted Date: 2021-11-18

Last Posted Date: 2024-03-01

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 992

Registration Number: NCT05124691

Locations: 🇪🇹
Bahir Dar University, Colleges of Medicine and Health Sciences (BDU-CMHS), Bahir Dar, Ethiopia
🇰🇪
Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
🇲🇿
Centro de Investigação em Saúde da Manhiça (CISM), Manhiça, Maputo, Mozambique

MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention

Recruiting

Conditions: Malaria

First Posted Date: 2021-10-20

Last Posted Date: 2024-08-15

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 45000

Registration Number: NCT05085340

Locations: 🇸🇱
College of Medicine & Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone
🇲🇿
Fundaçao Manhiça, Manhiça, Mozambique
🇹🇬
University of Lomé, Lomé, Togo

SARS-CoV-2 and Acetylsalicylic Acid (SARA)

Phase 3

Completed

Conditions: SARS-CoV2 Infection
Covid19

Interventions: Drug: Placebo
Drug: Low-dose acetylsalicylic acid

First Posted Date: 2021-10-11

Last Posted Date: 2024-08-15

Lead Sponsor: Barcelona Institute for Global Health

Target Recruit Count: 38

Registration Number: NCT05073718

Locations: 🇪🇸
Hospital Sant Joan de Déu, Barcelona, Catalunya, Spain
🇪🇸
Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain
🇲🇿
Universidade Eduardo Mondlane, Maputo, Mozambique

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy